LICHTLEITERKÖRPER

Patent europeic · EP4162919 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4162919
Numer da la dumonda
EP21817420
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
04-06-2021
Publitgà
12-04-2023
Concedì
10-12-2025
La protecziun finescha il pli tard
03-06-2041
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
A61J 15/00 (2006.01)
Prioritad
JP 2020097941 04.06.2020
Dumonda PCT
PCT/JP2021/021378 04.06.2021
Publicaziun PCT
WO2021/246520 09.12.2021
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 10-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.12.2025

Partidas

Possessur

Otsuka Clinical Solutions, Inc.

5194-63, Katsurenhaebaru, Uruma, Okinawa 904-2311, JP

Pax Co., Ltd.

3-1-5205, Kachidoki 6-chome Chuo-ku, Tokyo 104-0054, JP

Otsuka Pharmaceutical Factory, Inc.

115 Aza-Kuguhara Tateiwa Muya-cho Naruto-shi, Tokushima 772-8601, JP

Inventur

MIIKE, Shinya

Tokyo 113-0033, JP

ENDOH, Hiroshi

Tokyo 113-0033, JP

FURUYAMA, Takeshi

Tokyo 113-0033, JP

SUZUKI, Yutaka

Tokyo 104-0054, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.